CD73 inhibition enhances immune surveillance in pancreatic cancer
Lincoln Strickland, Research Assistant at UTHealth, shared a post on X about a recent paper by Jennifer Bailey Lundberg et al. titled “Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia” published in Cancer Prevention Research.
Authors: Lincoln N. Strickland, Wendao Liu, Usama Hussein, Nicolette Mardik, Xian Chen, Tingting Mills, Lana A. Vornik, Michelle I. Savage, Shizuko Sei, John Clifford, Holger K. Eltzschig, Powel H. Brown, Zhongming Zhao, Florencia McAllister, Jennifer M. Bailey-Lundberg.
“So proud to share my first first-author original research paper! Thank you to everyone who helped with this project, especially Jennifer Bailey Lundberg, co-first author Wendao Liu, and my friend Nicolette Mardik.”
Jennifer Bailey Lundberg shared this post, adding:
“Can inhibition of CD73 reduce pancreatic intraepithelial neoplasia progression and enhance immune surveillance? The dedicated work of Lincoln Strickland, Wendao Liu and our colleagues published in Cancer Prevention Research suggest yes. Congrats to Lincoln, Wendao and the team!”
Sources: Lincoln Strickland/X and Jennifer Bailey Lundberg/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023